
Gary Jackson
Supervisory Patent Examiner (ID: 5661, Phone: (571)272-4697 , Office: P/3769 )
| Most Active Art Unit | 3731 |
| Art Unit(s) | 3304, 3308, 4158, 3727, 3309, 2899, 3734, 3792, 3731, 3407, 3769 |
| Total Applications | 2094 |
| Issued Applications | 1632 |
| Pending Applications | 166 |
| Abandoned Applications | 295 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7169770
[patent_doc_number] => 20050202498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Poly-zinc finger proteins with improved linkers'
[patent_app_type] => utility
[patent_app_number] => 11/110594
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16600
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202498.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110594
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110594 | Nucleic acid encoding poly-zinc finger proteins with improved linkers | Apr 19, 2005 | Issued |
Array
(
[id] => 4687682
[patent_doc_number] => 20080031863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'Method of Preparation and Use of Fibrinolytic Enzymes in the Treatment of Disease'
[patent_app_type] => utility
[patent_app_number] => 11/587266
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6691
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20080031863.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587266
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587266 | Method of Preparation and Use of Fibrinolytic Enzymes in the Treatment of Disease | Apr 19, 2005 | Abandoned |
Array
(
[id] => 5834633
[patent_doc_number] => 20060246463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes'
[patent_app_type] => utility
[patent_app_number] => 11/110010
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3692
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246463.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110010
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110010 | Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes | Apr 19, 2005 | Abandoned |
Array
(
[id] => 5367258
[patent_doc_number] => 20090304817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Glycosylation Variants of Ricin-Like Proteins'
[patent_app_type] => utility
[patent_app_number] => 10/593958
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 18327
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593958
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593958 | Glycosylation Variants of Ricin-Like Proteins | Mar 23, 2005 | Abandoned |
Array
(
[id] => 456190
[patent_doc_number] => 07244575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-17
[patent_title] => 'Soluble complex comprising a retroviral surface glycoprotein'
[patent_app_type] => utility
[patent_app_number] => 11/088599
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 20443
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/244/07244575.pdf
[firstpage_image] =>[orig_patent_app_number] => 11088599
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/088599 | Soluble complex comprising a retroviral surface glycoprotein | Mar 23, 2005 | Issued |
Array
(
[id] => 4688139
[patent_doc_number] => 20080032320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'Method of Screening Compound Capable of Accelerating or Inhibiting Apoptosis, Apoptosis Accelarator and Apoptosis Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/594448
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 11466
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20080032320.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594448
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594448 | Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelarator and apoptosis inhibitor | Mar 22, 2005 | Issued |
Array
(
[id] => 7069474
[patent_doc_number] => 20050244859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Cell based assay'
[patent_app_type] => utility
[patent_app_number] => 11/081049
[patent_app_country] => US
[patent_app_date] => 2005-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9289
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244859.pdf
[firstpage_image] =>[orig_patent_app_number] => 11081049
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/081049 | Cell based assay | Mar 13, 2005 | Abandoned |
Array
(
[id] => 6996280
[patent_doc_number] => 20050136058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Insulin-like growth factor binding protein (IGFBP-5)'
[patent_app_type] => utility
[patent_app_number] => 11/056824
[patent_app_country] => US
[patent_app_date] => 2005-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17318
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136058.pdf
[firstpage_image] =>[orig_patent_app_number] => 11056824
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/056824 | Insulin-like growth factor binding protein (IGFBP-5) | Feb 10, 2005 | Abandoned |
Array
(
[id] => 5028882
[patent_doc_number] => 20070270329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof'
[patent_app_type] => utility
[patent_app_number] => 11/055587
[patent_app_country] => US
[patent_app_date] => 2005-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12911
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270329.pdf
[firstpage_image] =>[orig_patent_app_number] => 11055587
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/055587 | Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof | Feb 7, 2005 | Issued |
Array
(
[id] => 7178191
[patent_doc_number] => 20050123990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Membrane associated proteins'
[patent_app_type] => utility
[patent_app_number] => 11/048692
[patent_app_country] => US
[patent_app_date] => 2005-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39803
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123990.pdf
[firstpage_image] =>[orig_patent_app_number] => 11048692
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/048692 | Membrane associated proteins | Feb 1, 2005 | Abandoned |
Array
(
[id] => 5777560
[patent_doc_number] => 20060106200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Soluble, functional apoptotic protease-activating factor 1 fragments'
[patent_app_type] => utility
[patent_app_number] => 11/045540
[patent_app_country] => US
[patent_app_date] => 2005-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13794
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106200.pdf
[firstpage_image] =>[orig_patent_app_number] => 11045540
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/045540 | Soluble, functional apoptotic protease-activating factor 1 fragments | Jan 27, 2005 | Issued |
Array
(
[id] => 5771900
[patent_doc_number] => 20050267211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense'
[patent_app_type] => utility
[patent_app_number] => 11/038883
[patent_app_country] => US
[patent_app_date] => 2005-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16524
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267211.pdf
[firstpage_image] =>[orig_patent_app_number] => 11038883
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/038883 | Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense | Jan 18, 2005 | Abandoned |
Array
(
[id] => 7196521
[patent_doc_number] => 20050164334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Compaction assay for assessment of respiratory disease therapy'
[patent_app_type] => utility
[patent_app_number] => 11/033358
[patent_app_country] => US
[patent_app_date] => 2005-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8107
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164334.pdf
[firstpage_image] =>[orig_patent_app_number] => 11033358
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/033358 | Compaction assay for assessment of respiratory disease therapy | Jan 9, 2005 | Issued |
Array
(
[id] => 6966013
[patent_doc_number] => 20050232910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Anti-Listeria bacteriocin'
[patent_app_type] => utility
[patent_app_number] => 11/028505
[patent_app_country] => US
[patent_app_date] => 2005-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5050
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232910.pdf
[firstpage_image] =>[orig_patent_app_number] => 11028505
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/028505 | Anti-Listeria bacteriocin | Jan 3, 2005 | Issued |
Array
(
[id] => 578941
[patent_doc_number] => 07456250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-25
[patent_title] => 'Thrombin peptide derivative dimers'
[patent_app_type] => utility
[patent_app_number] => 11/027795
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7280
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/456/07456250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11027795
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/027795 | Thrombin peptide derivative dimers | Dec 29, 2004 | Issued |
Array
(
[id] => 270358
[patent_doc_number] => 07563594
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Cytolethal distending toxins and detection of Campylobacter bacteria using the same as a target'
[patent_app_type] => utility
[patent_app_number] => 10/581757
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 13550
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563594.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581757
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581757 | Cytolethal distending toxins and detection of Campylobacter bacteria using the same as a target | Dec 2, 2004 | Issued |
Array
(
[id] => 7233836
[patent_doc_number] => 20050079538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Secreted proteins'
[patent_app_type] => utility
[patent_app_number] => 11/002844
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39321
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079538.pdf
[firstpage_image] =>[orig_patent_app_number] => 11002844
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/002844 | Secreted proteins | Nov 29, 2004 | Abandoned |
Array
(
[id] => 442555
[patent_doc_number] => 07256017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-14
[patent_title] => 'Methods for generating lepidopteran-toxic polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/999188
[patent_app_country] => US
[patent_app_date] => 2004-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 58425
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/256/07256017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10999188
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/999188 | Methods for generating lepidopteran-toxic polypeptides | Nov 28, 2004 | Issued |
Array
(
[id] => 7111066
[patent_doc_number] => 20050208521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Therapeutic and diagnostic agents'
[patent_app_type] => utility
[patent_app_number] => 10/991181
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 89
[patent_figures_cnt] => 89
[patent_no_of_words] => 31447
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208521.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991181
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991181 | Therapeutic and diagnostic agents | Nov 16, 2004 | Issued |
Array
(
[id] => 7098436
[patent_doc_number] => 20050130895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Verotoxin pharmaceutical compositions and medical treatments therewith'
[patent_app_type] => utility
[patent_app_number] => 10/987990
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7884
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130895.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987990 | Verotoxin pharmaceutical compositions and medical treatments therewith | Nov 11, 2004 | Issued |